Researchers from NYU Grossman School of Medicine found people previously infected with the SARS-CoV-2 coronavirus may produce enough antibodies against COVID-19 after one dose of the Pfizer–BioNTech COVID-19 vaccine that is equal to or higher than people not previously infected have after two vaccinations.
Read More
![](https://covid19.healthcare.pro/wp-content/uploads/2021/03/park-5528190.jpg)